Found: 28
Select item for more details and to access through your institution.
In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2.
- Published in:
- PLoS ONE, 2024, v. 19, n. 4, p. 1, doi. 10.1371/journal.pone.0301086
- By:
- Publication type:
- Article
Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle.
- Published in:
- BMC Complementary Medicine & Therapies, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12906-023-04303-2
- By:
- Publication type:
- Article
Evaluation of Predicted siRNA as an Antiviral against MERS-CoV Targeting the Membrane Gene in the Vero Cell Line.
- Published in:
- Microbiology Research, 2023, v. 14, n. 4, p. 1687, doi. 10.3390/microbiolres14040116
- By:
- Publication type:
- Article
In vitro antiviral effect of cinnamon oil, Moringa oleifera extract, Manuka honey, and Nigella sativa oil against SARS-CoV-2 compared to remdesivir.
- Published in:
- Bulletin of the National Research Centre, 2023, v. 47, n. 1, p. 1, doi. 10.1186/s42269-023-01136-4
- By:
- Publication type:
- Article
Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1628, doi. 10.3390/vaccines11111628
- By:
- Publication type:
- Article
Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1397, doi. 10.3390/vaccines11091397
- By:
- Publication type:
- Article
Potential role of PIM1 inhibition in the treatment of SARS-CoV-2 infection.
- Published in:
- Journal of Genetic Engineering & Biotechnology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s43141-023-00520-x
- By:
- Publication type:
- Article
Chemical Profile, Antibacterial, Antibiofilm, and Antiviral Activities of Pulicaria crispa Most Potent Fraction: An In Vitro and In Silico Study.
- Published in:
- Molecules, 2023, v. 28, n. 10, p. 4184, doi. 10.3390/molecules28104184
- By:
- Publication type:
- Article
Essential Oil of Cestrum diurnum L.: GC/MS Analysis, in Vitro and in Silico Anti‐HCoV‐229E Effects and Inhibitory Activity against LPS‐Induced Inflammation.
- Published in:
- Chemistry & Biodiversity, 2023, v. 20, n. 4, p. 1, doi. 10.1002/cbdv.202201045
- By:
- Publication type:
- Article
Antiviral activities of plant-derived indole and β-carboline alkaloids against human and avian influenza viruses.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-27954-0
- By:
- Publication type:
- Article
Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt.
- Published in:
- Pathogens, 2023, v. 12, n. 1, p. 36, doi. 10.3390/pathogens12010036
- By:
- Publication type:
- Article
Immunogenicity and effectiveness of a bivalent influenza A/H1N2 vaccine strain against seasonal human influenza A viruses in mice.
- Published in:
- Journal of Genetic Engineering & Biotechnology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s43141-022-00436-y
- By:
- Publication type:
- Article
Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach.
- Published in:
- Molecules, 2022, v. 27, n. 18, p. 5923, doi. 10.3390/molecules27185923
- By:
- Publication type:
- Article
Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17573-6
- By:
- Publication type:
- Article
Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269321
- By:
- Publication type:
- Article
Prevalence of viral pathogens in a sample of hospitalized Egyptian children with acute lower respiratory tract infections: a two-year prospective study.
- Published in:
- Bulletin of the National Research Centre, 2022, v. 46, n. 1, p. 1, doi. 10.1186/s42269-022-00790-4
- By:
- Publication type:
- Article
Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.
- Published in:
- Influenza & Other Respiratory Viruses, 2021, v. 15, n. 6, p. 750, doi. 10.1111/irv.12889
- By:
- Publication type:
- Article
Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2.
- Published in:
- Molecules, 2021, v. 26, n. 21, p. 6559, doi. 10.3390/molecules26216559
- By:
- Publication type:
- Article
In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine.
- Published in:
- Molecules, 2021, v. 26, n. 20, p. 6182, doi. 10.3390/molecules26206182
- By:
- Publication type:
- Article
Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo Studies.
- Published in:
- Molecules, 2021, v. 26, n. 19, p. 5844, doi. 10.3390/molecules26195844
- By:
- Publication type:
- Article
Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 3, p. 1, doi. 10.1371/journal.ppat.1009413
- By:
- Publication type:
- Article
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 214, doi. 10.3390/vaccines9030214
- By:
- Publication type:
- Article
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 12, p. 443, doi. 10.3390/ph13120443
- By:
- Publication type:
- Article
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors.
- Published in:
- Frontiers in Microbiology, 2020, v. 11, p. N.PAG, doi. 10.3389/fmicb.2020.596851
- By:
- Publication type:
- Article
Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0241471
- By:
- Publication type:
- Article
PA from a Recent H9N2 (G1-Like) Avian Influenza A Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammalian Systems.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 9, p. 1046, doi. 10.3390/v12091046
- By:
- Publication type:
- Article
A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice.
- Published in:
- Pathogens, 2019, v. 8, n. 4, p. 281, doi. 10.3390/pathogens8040281
- By:
- Publication type:
- Article
Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV.
- Published in:
- Vaccines, 2019, v. 7, n. 2, p. 46, doi. 10.3390/vaccines7020046
- By:
- Publication type:
- Article